Frameshift mutations induced by four isomeric nitroacridines and their des-nitro counterpart in the lacZ reversion assay in Escherichia coli

Environmental and Molecular Mutagenesis

Volumn 47, Issue 2, 2006, Pages 82-94

  Hoffmann, George R ^a   Yin, Catherine C ^a   Terry, Caitlin E ^a   Ferguson, Lynnette R ^b   Denny, William A ^b  

^a Center for Interdisciplinary Studies   (United States)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Acridine; Entozon; Frameshift; lacZ; Ledakrin; Nitracrine; Nitroacridine; Slipped mispairing

Indexed keywords

2 NITRO 9 (3' DIMETHYLAMINOPROPYLAMINO)ACRIDINE; 3 NITRO 9 (3' DIMETHYLAMINOPROPYLAMINO)ACRIDINE; 4 NITRO 9 (3' DIMETHYLAMINOPROPYLAMINO)ACRIDINE; 6 CHLORO 9 [3 (2 CHLOROETHYL)AMINOPROPYLAMINO] 2 METHOXYACRIDINE; 9 (3' DIMETHYLAMINOPROPYLAMINO)ACRIDINE; ACRIDINE DERIVATIVE; ADENINE; AMINOACRIDINE; BETA GALACTOSIDASE; DNA BASE; GUANINE; NITRACRINE; NITROACRIDINE; NITROAKRIDIN 3582; UNCLASSIFIED DRUG;

ARTICLE; BASE PAIRING; CONTROLLED STUDY; COVALENT BOND; DNA BINDING; DRUG STRUCTURE; ESCHERICHIA COLI; FRAMESHIFT MUTATION; ISOMER; MUTAGENESIS; MUTAGENICITY; NONHUMAN; REVERTANT; STRUCTURE ANALYSIS;

ACRIDINES; ANTINEOPLASTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCHERICHIA COLI; FRAMESHIFT MUTATION; LAC OPERON; MOLECULAR STRUCTURE; MUTAGENICITY TESTS; NITRACRINE;

BRASSICACEAE; ESCHERICHIA COLI;

EID: 33644610349     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/em.20171     Document Type: Article

References (64)

1. 32P-post-labeling analysis of DNA adduct formation by antitumor drug nitracrine (Ledakrin) and other nitroacridines in different biological systems. Biochem Pharmacol 38:1301-1312.
2. 32P-Post-labelling analysis of nucleobases involved in the formation of DNA adducts by antitumor 1-nitroacridines. Chem Biol Interact 103:131-139.
3. Bartoszek A, Dackiewicz P, Skladanowski A, Konopa J. 1997b. In vitro DNA crosslinking by Ledakrin, an antitumor derivative of 1-nitro-9-aminoacridine. Chem-Biol Interact 103:141-151.
4. Becherel OJ, Fuchs RPP. 2001. Mechanism of DNA polymerase II-mediated frameshift mutagenesis. Proc Natl Acad Sci USA 98:8566-8571.
5. Brown BR, Firth WJ, III, Yielding LW. 1980. Acridine structure correlated with mutagenic activity in Salmonella. Mutat Res 72:373-388.
6. Carroll CC, Warnakulasuriyarachchi D, Nokhbeh MR, Lambert IB. 2002. Salmonella typhimurium mutagenicity tester strains that overexpress oxygen-insensitive nitroreductases nfsA and nfsB. Mutat Res 501:79-98.
7. Cebula TA, Koch WH. 1990. Sequence analysis of Salmonella typhimurium revenants. In: Mendelsohn ML, Albertini RJ, editors. Mutation and the Environment, Part D. New York: Wiley. pp 367-377.
8. Cupples CG, Miller JH. 1989. A set of lacZ mutations in Escherichia coli that allow rapid detection of each of the six base substitutions. Proc Natl Acad Sci USA 86:5345-5349.
9. Cupples CG, Cabrera M, Cruz C, Miller JH. 1990. A set of lacZ mutations in Escherichia coli that allow rapid detection of specific frameshift mutations. Genetics 125:275-280.
10. DeMarini DM, Shelton ML, Abu-Shakra A, Szakmary A, Levine JG. 1998. Spectra of spontaneous frameshift mutations at the hisD3052 allele of Salmonella typhimurium in four DNA repair backgrounds. Genetics 149:17-36.
11. Denny WA, Atwell GJ, Anderson RF, Wilson WR. 1990. Hypoxia-selective antitumor agents. 4. Relationships between structure, physicochemical properties, and hypoxia-selective cytotoxicity for nitracrine analogues with varying side chains: the "iminoacridan hypothesis." J Med Chem 33:1288-1295.
12. Ferguson LR, Denny WA. 1990. Frameshift mutagenesis by acridines and other reversibly-binding DNA Iigands. Mutagenesis 5:529-540.
13. Ferguson LR, Denny WA. 1991. The genetic toxicology of acridines. Mutat Res 258:123-160.
14. Ferguson LR, Turner PM. 1987a. Frameshift mutagenesis by nitracrine analogues in wild-type, uvrB, polA and recA strains of Salmonella typhimurium, with and without plasmid pKM101. Mutat Res 184:13-21.
15. Ferguson LR, Turner PM. 1987b. Mutagenic, recombinogenic, and antimitochondrial effects of nitracrine analogues in Saccharomyces cerevisiae. Mutat Res 187:209-217.
16. Ferguson LR, van Zijl P. 1988. Mutagenic and clastogenic activity of nitracrine analogues in cultured V79 Chinese hamster cells. Mutat Res 204:655-663.
17. Ferguson LR, Denny WA, MacPhee DG. 1985. Three consistent patterns of response to substituted acridines in a variety of bacterial tester strains used for mutagenicity testing. Mutat Res 157:29-37.
18. Ferguson LR, Turner PM, Denny WA. 1987. Mutagenicity of nitracrine analogues in Salmonella typhimurium: mutational specificity and activation by bacterial enzymes and rat-liver S9. Mutat Res 187:1-9.
19. Fujii S, Akiyama M, Aoki K, Sugaya Y, Higuchi K, Hiraoka M, Miki Y, Saitoh N, Yoshiyama K, Ihara K, Seki M, Ohtsubo E, Maki H. 1999. DNA replication errors produced by the replicative apparatus of Escherichia coli. J Mol Biol 289:835-850.
20. Garcia A, Lambert IB, Fuchs RPP. 1993. DNA adduct-induced stabilization of slipped frameshift intermediates within repetitive sequences: implications for mutagenesis. Proc Natl Acad Sci USA 90: 5989-5993.
21. Gniazdowski M, Szmigiero L. 1995. Nitracrine and its congeners - an overview. Gen Pharmacol 26:473-481.
22. Gorlewska K, Mazerska Z, Sowinski P, Konopa J. 2001. Products of metabolic activation of the antitumor drug ledakrin (nitracrine) in vitro. Chem Res Toxicol 14:1-10.
23. Hilario P, Yan S, Hingerty BE, Broyde S, Basu AK. 2002. Comparative mutagenesis of the C8-guanine adducts of 1-nitropyrene and 1,6- and 1,8-dinitropyrene in a CpG repeat sequence. J Biol Chem 277:45068-45074.
24. Hoffmann GR, Fuchs RPP. 1997. Mechanisms of frameshift mutations: insight from aromatic amines. Chem Res Toxicol 10:347-359.
25. Hoffmann GR, Deschênes SM, Manyin T, Fuchs RPP. 1996. Mutagenicity of acridines in a reversion assay based on tetracycline resistance in plasmid pBR322 in Escherichia coli. Mutat Res 351:33-43.
26. Hoffmann GR, Calciano MA, Lawless BM, Mahoney KM. 2003. Frameshift mutations induced by three classes of acridines in the lacZ reversion assay in Escherichia coli: potency of responses and relationship to slipped mispairing models. Environ Mol Mutagen 42:111-121.
27. Josephy PD. 1989. New developments in the Ames assay: high-sensitivity detection of mutagenic arylamines. Bioessays 11:108-112.
28. Josephy PD. 2000. The Escherichia coli lacZ reversion mutagenicity assay. Mutat Res 455:71-80.
29. Josephy PD, Gruz P, Nohmi T. 1997. Recent advances in the construction of bacterial genotoxicity assays. Mutat Res 386:1-23.
30. Kalinowska E, Chorazy M. 1980. Mutagenic activity of some 9-aminoalkyl acridine derivatives on S. typhimurium. Mutat Res 78:7-15.
31. Kirchner JM, Tran H, Resnick MA. 2000. A DNA polymerase ε mutant that specifically causes +1 frameshift mutations within homonucleotide runs in yeast. Genetics 155:1623-1632.
32. Koffel-Schwartz N, Fuchs RPP. 1995. Sequence determinants for-2 frameshift mutagenesis at NarI-derived hot spots. J Mol Biol 252: 507-513.
33. Kohn KW, Hartley JA, Mattes WB. 1987. Mechanisms of DNA sequence selective alkylation of guanine-N7 positions by nitrogen mustards. Nucleic Acids Res 15:10531-10549.
34. Kranendonk M, Commandeur JNM, Laires A, Rueff J, Vermeulen NPE. 1997. Characterization of enzyme activities and cofactors involved in bioactivation and bioinactivation of chemical carcinogens in the tester strains Escherichia coli K12 MX100 and Salmonella typhimurium LT2 TA100. Mutagenesis 12:245-254.
35. Lambert IB, Gordon AJE, Glickman BW, McCalla DR. 1992. The influence of local DNA sequence and DNA repair background on the mutational specificity of 1-nitroso-8-nitropyrene in Escherichia coli: inferences for mutagenic mechanisms. Genetics 132:911-927.
36. Lambert IB, Carroll C, Laycock N, Duval L, Whiteway J, Lawford I, Turner G, Booth R, Douville S, Nokhbeh MR. 1998. The mutational specificity of 1-nitroso-6-nitropyrene in the lacI gene of Escherichia coli strains deficient in nucleotide excision repair. Mutagenesis 13:9-18.
37. Lambert IB, Carroll C, Laycock N, Koziarz J, Lawford I, Duval L, Turner G, Booth R, Douville S, Whiteway J, Nokhbeh MR. 2001. Cellular determinants of the mutational specificity of 1-nitroso-6-nitropyrene and 1-nitroso-8- nitropyrene in the lacI gene of Escherichia coli. Mutat Res 484:19-48.
38. 9-derivatives of 1-, 2-, 3- and 4-nitro-9-aminoacridine. Roczn Chem 40:301-306.
39. 9pochodne 9-aminoakrydyny Roczn Chem 38:1111-1114.
40. Lerman LS. 1961. Structural considerations in the interactions of DNA and acridines. J Mol Biol 3:18-30.
41. MacPhee DG, Liaskou D. 1989. Mutagenesis by the anti-tumour drug nitracrine in Escherichia coli. Mutat Res 227:251-255.
42. McCoy EC, Rosenkranz EJ, Petrullo LA, Rosenkranz HS. 1981. Frameshift mutations: relative roles of simple intercalation and of adduct formation. Mutat Res 90:21-30.
43. Milhé C, Dhalluin C, Fuchs RPP, Lefèvre J-F. 1994. NMR evidence of the stabilisation by the carcinogen N-2-acetylaminofluorene of a frameshift mutagenesis intermediate. Nucleic Acids Res 22:4646-4652.
44. Milhé C, Fuchs RPP, Lefèvre J-F. 1996. NMR data show that the carcinogen N-2-acetylaminofluorene stabilises an intermediate of -2 frameshift mutagenesis in a region of high mutation frequency. Eur J Biochem 235:120-127.
45. Neidle S, Abraham Z. 1984. Structural and sequence-dependent aspects of drug intercalation into nucleic acids. CRC Crit Rev Biochem 17:73-121.
46. Nokhbeh MR, Boroumandi S, Pokorny N, Koziarz P, Paterson ES, Lambert IB. 2002. Identification and characterization of SnrA, an inducible oxygen-insensitive nitroreductase in Salmonella enterica serovar Typhimurium TA1535. Mutat Res 508:59-70.
47. O'Connor CJ, McLennan DJ, Denny WA, Sutton BM. 1990. Substituent effects on the hydrolysis of analogues of nitracrine (9-[3-(N,N-dimethylamino) propylamino]-1-nitroacridine). J Chem Soc Perkin Trans 2:1637-1641.
48. 2B are responsible for their different mutagenic properties during bypass of a T-T cis-syn cyclobutane dimer. J Bacteriol 182:2283-2291.
49. Pawlak K, Pawlak JW, Konopa J. 1984. Cytotoxic and antitumor activity of 1-nitroacridines as an aftereffect of their interstrand DNA cross-linking. Cancer Res 44:4289-4296.
50. Roberts PB, Denny WA, Wakelin LPG, Anderson RF, Wilson WR. 1990. Radiosensitization of mammalian cells in vitro by nitroacridines. Radiat Res 123:153-164.
51. Sagher D, Hsu A, Strauss B. 1999. Stabilization of the intermediate in frameshift mutation. Mutat Res 423:73-77.
52. Sahasrabudhe SR, Luo X, Humayun MZ. 1991. Specificity of base substitutions induced by the acridine mutagen ICR-191: mispairing by guanine N7 adducts as a mutagenic mechanism. Genetics 129:981-989.
53. Sambrook J, Fritsch EF, Maniatis T. 1989. Molecular Cloning. Cold Spring Harbor, NY: Cold Spring Harbor Press.
54. Schaaper RM, Koffel-Schwartz N, Fuchs RPP. 1990. N-Acetoxy-N-acetyl-2- aminofluorene-induced mutagenesis in the lacI gene of Escherichia coli. Carcinogenesis 11:1087-1095.
55. Shelton ML, DeMarini DM. 1995. Mutagenicity and mutation spectra of 2-acetylaminofluorene at frameshift and base-substitution alleles in four DNA repair backgrounds of Salmonella. Mutat Res 327: 75-86.
56. Siim BG, Denny WA, Wilson WR. 1997. Nitro reduction as an electronic switch for bioreductive drug activation. Oncol Res 9:357-369.
57. Siim BG, Hicks KO, Pullen SM, van Zijl PL, Denny WA, Wilson WR. 2000. Comparison of aromatic and tertiary amine N-oxides of acridine DNA intercalators as bioreductive drugs: cytotoxicity. DNA binding, cellular uptake, and metabolism. Biochem Pharmacol 60:969-978.
58. Streisinger G, Okada Y, Emrich J, Newton J, Tsugita A, Terzaghi E, Inouye M. 1966. Frameshift mutations and the genetic code. Cold Spring Harb Symp Quant Biol 31:77-84.
59. Stezowski JJ, Kollat P, Bogucka-Ledóchowska M, Glusker JP. 1985. Tautomerism and steric effects in 1-nitro-9-(alkylamino)acridines (ledakrin or nitracrine analogues): probing structure-activity relationships at the molecular level. J Am Chem Soc 107:2067-2077.
60. Vogel HJ, Bonner DM. 1956. Acetylornithinase of E. coli: a partial purification and some properties. J Biol Chem 218:97-106.
61. Watanabe M, Nishino T, Takio K, Sofuni T, Nohmi T. 1998. Purification and characterization of wild-type and mutant "classical" nitroreductases of Salmonella typhimurium: L33R mutation greatly diminishes binding of FMN to the nitroreductase of S. typhimurium. J Biol Chem 273:23922-23928.
62. Wilson WR, Denny WA, Twigden SJ, Baguley BC, Probert JC. 1984. Selective toxicity of nitracrine to hypoxic mammalian cells. Br J Cancer 49:215-223.
63. Wilson WR, Thompson LH, Anderson RF, Denny WA. 1989. Hypoxia-selective antitumor agents. 2. Electronic effects of 4-sutstituents on the mechanisms of cytotoxicity and metabolic stability of nitracrine derivatives. J Med Chem 32:31-38.
64. Yamada M, Espinosa-Aguirre JJ, Watanabe M, Matsui K, Sofuni T, Nohmi T. 1997. Targeted disruption of the gene encoding the classical nitroreductase enzyme in Salmonella typhimurium Ames test strains TA1535 and TA1538. Mutat Res 375:9-17.